Is Growth Conceding?

December 02, 2020 | Jessica Noviskis, CFA, Portfolio Strategist, OCIO Services

The market’s continued rally following the U.S. election has been a welcome relief, even more so for value investors. Since major media outlets called the presidential race for now President-elect Biden on November 7th, the Russell 1000 Value Index has outperformed the Russell 1000 Growth Index by 6.6%, and at one point by more than 10%. It has been the strongest value run since the dot-com bubble burst in 2001. The Monday following the result, November 9th, was the best single day for value over growth ever.

Presidential elections and other regime changes can often spark a rotation within the market. In this case, in addition to expectations for additional stimulus post the election, the delayed election results lined up with Pfizer’s announcement — and the peer announcements that followed — that its COVID-19 vaccine candidate was found to be more than 90% effective. Stocks generally, but in particular, more cyclical businesses and industries most impacted by the pandemic, rallied and have continued to gain momentum. Banks are up 20% and Energy stocks more than 30%. Technology and Healthcare have lagged despite the Republican gains in Congress that subsequently reduced the risk of sweeping regulatory changes.

The question now is whether value can maintain this momentum. Interestingly, the move is reminiscent of the period following the 2016 election. From the election on November 8th, 2016 to a peak in mid-December, value had outpaced growth by 5%. Financials, along with Energy and Basic Materials, led at that point as well, though for different reasons, set to benefit from expected regulatory rollbacks, tax cuts, and protectionist trade policies. Technology unsurprisingly lagged following Trump’s attacks on Tech bellwethers throughout his campaign. But the high expectations fizzled as Trump’s agenda hit roadblocks. In 2016, value’s advantage lasted roughly a month, with growth back on top by mid-March 2017. Only time will tell how market dynamics will play out this time. Relative to growth, value is trading at some of the most attractive valuations ever. But several of the same trends that led to growth’s dominance over the last decade, and certainly this year, are also arguably stronger than ever.

Print PDF > Is Growth Conceding?

 

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Jessica Noviskis, CFA
Portfolio Strategist, OCIO Services

Get to Know Jessica

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Related Content

Combination stacked column and line chart showing U.S. Buyout (private equity) Net Asset Value holding periods, 2011 to 2025. Column categories include holding periods

08.31.2026

Zombie, Inc.

Private equity has always had a few portfolio companies that refused to leave the party. Today, however, the industry appears…

Five-line chart comparing yield on 30-year debt instrument for the United States, United Kingdon, France, Germany, and Japan, December 2021 to August 21, 2026. First data point in order listed previously: 1.9%, 1.1%, 0.9%, 0.2%, 0.7%. Most recent: 5.3%, 5.8%, 4.9%, 3.8%, 4.1%. For full dataset, please contact marquettemarketing@marquetteassociates.com.

08.24.2026

Long Weakened

The global bond market is facing renewed pressure as investors demand higher yields to hold long-dated government debt, pushing borrowing…

Column chart showing total deal size for 14 non-financial corporate bond deals of $20B or more since the start of 2025. Out of 14, only three were unrelated to AI or hyperscalers. For full dataset, please contact marquettemarketing@marquetteassociates.com.

08.17.2026

Supersize Me!

As a college football player struggling to put on mass, the “supersizing” deal at McDonald’s was hard to beat. For…

08.10.2026

The Yen is Wayward… but Investors Carry On

After reaching nearly ¥164 per dollar, its weakest level in roughly four decades, the yen had become a source of…

Combined column and line chart showing expected hikes/cuts and policy rate as of 12/31/2025 through 7/31/2025 as well as the actual policy rate for upcoming Fed meetings, 12/31/2025 through 12/9/2026. As market expectations have changed in 2026, investors' original outlook for two rate cuts were priced out in March and eventually switched to two rate hikes. For full dataset, please contact marquettemarketing@marquetteassociates.com.

08.03.2026

Hit the One in the Middle, Mr. Chairman!

In the cinematic masterpiece Rocky IV, Rocky gets dazed by his opponent, Captain Ivan Drago, and complains that he sees…

Column chart showing redemption volume for business development companies (PDCs) in billions of dollars by quarter, 1Q 2022 to 2Q 2026. Filled redemptions are shown in solid orange, but 1Q and 2Q 2026 also include stacked lighter orange for Unmet Redemptions data (-$6.5B and -$9.7B, respectively). Up to the second half of 2025, volume hovered at less than -$2B, but has since increased. For full dataset, please contact marquettemarketing@marquetteassociates.com.

07.27.2026

Liquidity Isn’t Free

The rapid growth of non-traded business development companies (BDCs), which are investment vehicles that pool investor capital to make loans…

More articles

Subscribe to Research Email Alerts

Research Email Alert Subscription

Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.

We respect your privacy. We will never share or sell your information.

Thank You

We appreciate your interest in Marquette Associates.

If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.

Contact Us >